The European Commission has approved new indications for pembrolizumab in combination with chemotherapy in select patients with gastric or gastroesophageal adenocarcinoma and select patients with biliary tract cancer.
India News: Dr. Prateek Sharma specializes in GI cancers and actively explores cutting-edge technologies such as digital health, artificial intelligence, and adva
Nov. 16 event in Washington, D.C., to honor five highly accomplished individuals for their dedication to finding cures and improving the lives of GI cancer.
Emerging treatments, particularly claudin 18.2, a potential new biomarker in the HER2-negative gastric and gastroesophageal junction cancer space, were highlights of the 2023 ASCO Gastrointestinal Cancers Symposium.